Ventriculo-peritoneal shunt infection due to non-equi Rhodococcus sp.
Lora-Tamayo
Jaime
J
Fernández-Sabé
Nuria
N
Viladrich
Pedro F
PF
Verdaguer
Ricard
R
Gabarrós
Andreu
A
D000193:Actinomycetales Infections / Q000175:diagnosis*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002442:Ceftazidime / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D012240:Rhodococcus / Q000302:isolation & purification*; D016896:Treatment Outcome; D014640:Vancomycin / Q000627:therapeutic use; D017287:Ventriculoperitoneal Shunt / Q000009:adverse effects*
D000900:Anti-Bacterial Agents; D014640:Vancomycin; D002442:Ceftazidime